Intrommune Therapeutics, Inc.
Biotechnology company · New York, United States
Intrommune Therapeutics, Inc. is a biotechnology company headquartered in New York, United States. Its earliest recorded incorporation is in 2021. It has reported private securities offerings to the US SEC, most recently $210,000 sold in a notice filed in 2024.
Intrommune Therapeutics at a glance
What does Intrommune Therapeutics do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $210,000 sold (2024).
Frequently asked questions about Intrommune Therapeutics
Where is Intrommune Therapeutics headquartered?
Intrommune Therapeutics, Inc. is headquartered in New York, United States.
What does Intrommune Therapeutics do?
Intrommune Therapeutics, Inc. is a biotechnology company.
When was Intrommune Therapeutics founded?
The earliest incorporation on record for Intrommune Therapeutics, Inc. is in 2021, according to public company registers.
Similar companies
- Lexeo Therapeutics, Inc.New York City, New York, United States
- MiNK Therapeutics, Inc.New York City, New York, United States
- IN8BIO, Inc.New York City, New York, United States
- Anavex Life Sciences Corp.New York City, New York, United States
- Brainstorm Cell Therapeutics Inc.New York City, New York, United States
- Bioincept LLCNew York City, New York, United States
- Protara Therapeutics, Inc.New York City, New York, United States
- Ancilia Biosciences, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences